Researchers found significantly higher levels of Lcn-2 levels in the stools of patients with multiple sclerosis. This marker correlated with reduced bacterial diversity and increases in other markers of intestinal inflammation. Bacteria that ease inflammatory bowel disease were also reduced in MS patients with high fecal levels of Lcn-2 levels.
Rather than being simply a brain disease, researchers propose Alzheimer's disease could be a disorder of the immune system within the brain.
Afimetoran, a newly developed pill to treat lupus, not only prevents lupus-like symptoms in mice, it also reverses signs of organ damage caused by the disease and prevents death. The medication is now undergoing phase 2 clinical trials to assess its effectiveness in lupus patients.
A new protein-based vaccine shows promise for improving bone quality and preventing rheumatoid arthritis.
A diet rich in foods containing isoflavone, a plant-based compound found in legumes, chickpeas, and peanuts, that resembles estrogen, protects against multiple sclerosis symptoms in mouse models.
A newly engineered compound prevents damage to myelin and nerve fibers by stimulating a protective response in cells that produce and maintain myelin. The compound has positive implications for the treatment of Multiple Sclerosis.
6-gingerol, the main bioactive compound of ginger root, appears to counteract mechanisms that fuel autoimmune disorders such as lupus and antiphospholipid syndrome in mice.
Schizophrenia may, in part, be caused by immune system dysfunction, a new study reports. Treatment with Methotrexate, a drug commonly prescribed for autoimmune disorders like R.A, produced positive effects against some prominent schizophrenia symptoms.
Recovery from multiple sclerosis-like symptoms in mice depends upon the ability for microglia to break down the remains of damaged cells.
Study reveals why some people with ALS are prone to developing autoimmune diseases. A genetic mutation that decreases the expression of C9orf72 causes the stimulation of interferon genes (STING) protein to become hyperactive. The hyperactivity leads to increased production of interferons. This can lead to systemic inflammation and the development of autoimmune diseases.
Celiac disease, an autoimmune response to ingesting gluten, has been linked to an increased risk of neurological damage and negative mental health outcomes. Those with celiac disease are more likely to experience depression, anxiety, and thoughts of self-harm, in addition to a reduction in reaction times and cognitive function. Neuroimaging of patients with the disorder reveals white matter changes in the brain.
Genetic testing can help identify children at risk of epilepsy, in addition to identifying new genetic mutations associated with the condition. Using CBD based medications can also help reduce seizures in children with epilepsy.